JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 10, 2005; DOI: 10.1124/jpet.105.087890


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.087890v1
315/1/118    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mancinelli, A.
Right arrow Articles by Longo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mancinelli, A.
Right arrow Articles by Longo, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH


Received for publication April 12, 2005.
Revised June 9, 2005.
Accepted for publication June 9, 2005.

Uptake of L-carnitine and its Short-chain Ester Propionyl-L-carnitine in the Isolated Perfused Rat Liver

Angelo Mancinelli 1*, Allan Mark Evans 2, Roger Nation 3, Antonio Longo 1

1 Sigma Tau SpA 2 School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia 3 Department of Pharmacy Practice, Victorian College of Pharmacy, Monash University, Melbourne, Au

* Address correspondence to: E-mail: angelo.mancinelli{at}sigma-tau.it

Abstract

Abstract Hepatic uptake of propionyl- (PLC) and L-carnitine (LC) was assessed with the impulse response (IR) technique in the single-pass perfused rat liver. The experiments involved a rapid injection (impulse) of a mixture of the radiolabeled test compound (propionyl- or L-carnitine) and a reference compound (sucrose) into portal vein inflow and collection and radiochemical analysis (response) of the venous outflowing perfusate samples. The impulse injection was made in the presence of increasing unlabeled background concentrations of PLC (0-50 µM) or LC (50-500 µM) perfusing the liver. For LC the hepatic uptake was minimal or negligible, whereas for PLC the hepatic influx clearance was found to be low (0.095 ml · sec-1 equivalent to 5.7 ml · min-1) relative to the perfusate flow rate (30 ml · min-1). When background concentrations of PLC were increased (from 1 to 50 µM) the influx clearance was reduced in a concentration-dependent behaviour, indicating partial saturation of the entry of compound into hepatocytes. PLC was taken up into hepatocytes via a unidirectional transport process with negligible efflux. The hepatic uptake of PLC was significally reduced in the presence of unlabeled LC (500 µM) indicating an inhibition of the sinusoidal membrane transport of PLC by LC. The study demonstrated the sinusoidal membrane is a permeability barrier to the entry of PLC and LC into hepatocytes and it is the site of a common carrier mediated transporter for both compounds.


Key words: L-carnitine, impulse response, liver, perfused, propionyl-L-carnitine, uptake





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.